BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.58B |
| 2 |
Microsoft
MSFT
|
+$3.36B |
| 3 |
GE Vernova
GEV
|
+$2.86B |
| 4 |
CRH
CRH
|
+$2.57B |
| 5 |
Amazon
AMZN
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.23B |
| 2 |
GE Aerospace
GE
|
+$1.37B |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$1.23B |
| 4 |
Super Micro Computer
SMCI
|
+$1.17B |
| 5 |
AbbVie
ABBV
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.27% |
| 2 | Healthcare | 12.09% |
| 3 | Financials | 11.69% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORGN
3751
DELISTED
Origin Materials
ORGN
| $2.23M | ﹤0.01% |
82,448
-190,601
| -70% | -$5.09M |
|
3752
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
| $2.22M | ﹤0.01% |
18,383
+1,220
| +7% | +$148K |
|
|
AY
3753
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $2.22M | ﹤0.01% |
101,102
-212,362
| -68% | -$4.45M |
|
3754
American Well
AMWL
$183M
| $2.22M | ﹤0.01% |
341,005
-692,117
| -67% | -$6.97M |
|
3755
BlackRock Short Maturity Municipal Bond ETF
MEAR
$1.36B
| $2.2M | ﹤0.01% |
43,917
-404,391
| -90% | -$20.2M |
|
|
MRNS
3756
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $2.19M | ﹤0.01% |
1,869,949
-2,850,612
| -60% | -$7.13M |
|
|
IVAC
3757
DELISTED
Intevac Inc
IVAC
| $2.18M | ﹤0.01% |
566,007
-1,206,872
| -68% | -$4.75M |
|
|
ATYR
3758
aTyr Pharma
ATYR
$48.2M
| $2.17M | ﹤0.01% |
1,392,074
+27,194
| +2% | +$47.3K |
|
|
KYNB
3759
Kyntra Bio
KYNB
$27.8M
| $2.15M | ﹤0.01% |
96,386
-182,331
| -65% | -$5.63M |
|
|
PDS
3760
Precision Drilling
PDS
$994M
| $2.14M | ﹤0.01% |
30,470
+11,036
| +57% | +$777K |
|
3761
Atour Lifestyle Holdings
ATAT
$4.75B
| $2.13M | ﹤0.01% |
116,212
+112,503
| +3,033% | +$2.03M |
|
3762
BV Financial
BVFL
$181M
| $2.12M | ﹤0.01% |
177,931
-42,687
| -19% | -$461K |
|
3763
Brookfield Asset Management
BAM
$81.1B
| $2.12M | ﹤0.01% |
55,668
+19,013
| +52% | +$747K |
|
3764
Meridian
MRBK
$236M
| $2.11M | ﹤0.01% |
200,776
+8,901
| +5% | +$85.1K |
|
3765
Vuzix
VUZI
$201M
| $2.09M | ﹤0.01% |
1,550,429
-3,064,957
| -66% | -$4.22M |
|
3766
Upland Software
UPLD
$12.9M
| $2.07M | ﹤0.01% |
83,286
-21,738
| -21% | -$572K |
|
|
CTEV
3767
Claritev Corp
CTEV
$411M
| $2.05M | ﹤0.01% |
131,712
-510,121
| -79% | -$12.1M |
|
3768
Innovative Solutions & Support
ISSC
$347M
| $2.05M | ﹤0.01% |
341,021
-33,881
| -9% | -$215K |
|
|
LOGC
3769
DELISTED
ContextLogic
LOGC
| $2.03M | ﹤0.01% |
355,251
-1,263,376
| -78% | -$6.95M |
|
3770
iShares Breakthrough Environmental Solutions ETF
ETEC
$4.24M
| $2.02M | ﹤0.01% |
100,000
-10,000
| -9% | -$215K |
|
3771
Red Robin
RRGB
$149M
| $2.02M | ﹤0.01% |
267,174
-744,062
| -74% | -$5.42M |
|
|
BOLD
3772
Boundless Bio
BOLD
$57.5M
| $2M | ﹤0.01% |
517,094
+367,094
| +245% | +$3.51M |
|
|
EARN
3773
Ellington Residential Mortgage REIT
EARN
$163M
| $1.98M | ﹤0.01% |
285,563
+60,714
| +27% | +$421K |
|
3774
Vanguard Morningstar Mid-Cap ETF
VO
$107B
| $1.98M | ﹤0.01% |
32,776
+29,280
| +838% | +$1.78M |
|
|
EGRX
3775
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.98M | ﹤0.01% |
352,762
-545,044
| -61% | -$2.37M |
|
Similar funds
BlackRock's Q2 2024 Portfolio in Review
As of Q2 2024, BlackRock held 5,453 positions worth $4.42T, up 2.9% from $4.3T the previous quarter. Its ten largest holdings account for 27% of the portfolio.
BlackRock's Q2 2024 filing shows 174 new, 2,441 increased, 2,110 reduced and 172 closed positions. Its largest new stake was Solventum: 11,038,924 shares worth $584M. The largest sale was Pioneer Natural Resource Co., an estimated $4.23B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2024 buy was Solventum: 11,038,924 shares worth $584M.
- BlackRock added most to ExxonMobil in Q2 2024, an estimated $3.58B increase.
- BlackRock's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $1.37B.
- BlackRock fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.23B.
- BlackRock's ten largest holdings make up 27% of its $4.42T portfolio in Q2 2024.
- BlackRock opened 174 new positions and closed 172 in Q2 2024.
- BlackRock's portfolio value rose 2.9% quarter-over-quarter to $4.42T.
Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.